News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Alexander Somjen

Alexander Somjen is the CEO and Director of Origin Therapeutics.

Articles by Alexander Somjen

Emerging Psychedelic Therapies

ByAlexander Somjen

November 4th 2021

Here's why psychedelics might be a valuable addition to mental health treatment.

Latest Updated Articles

Emerging Psychedelic Therapies
Published: November 4th 2021 | Updated:

Trending on Psychiatric Times

Insomnia in Older Adults: A Holistic Approach

Precision Diagnosis: The New Paradigm for Neurocognitive Disorders

Reflections on the Therapeutic Alliance in Clinical Practice

Can a Class Action Lawsuit Force Big AI to Make Chatbots Safer?

How To Analyze a Randomized Controlled Trial

© 2025 MJH Life Sciences^®

All rights reserved.